Íåêîòîðûå ðàííèå îñëîæíåíèÿ ðàí (T79)
Ïîñòòðàâìàòè÷åñêàÿ ðàíåâàÿ èíôåêöèÿ, íå êëàññèôèöèðîâàííàÿ â äðóãèõ ðóáðèêàõ
ÀÌÎÊÑÈÑÀЮÁÈÎÕÈÌÈÊ ÎÀÎ
ÀÐÃÎÑÓËÜÔÀÍPHARMACEUTICAL WORKS JELFA S.A.
ÀÓÃÌÅÍÒÈÍSmithKline Beecham Pharmaceuticals
ÁÈÖÈËËÈÍ®-3ÑÈÍÒÅÇ ÎÀÎ
ÂÓËÍÓÇÀÍPHARMACHIM HOLDING EAD/SOPHARMA AD
ÄÀËÜÖÅÊÑ-ÒÐÈÏÑÈÍÈíñòèòóò Òåêñòèëüíûõ Ìàòåðèàëîâ
ÄÅÐÈÍÀÒÒÅÕÍÎÌÅÄÑÅÐÂÈÑ ÇÀÎ ÔÏ
ËÀÂÀÑÅÏÒ ÊÎÍÖÅÍÒÐÀÒFRESENIUS KABI DEUTSCHLAND GmbH
ËÈÊÎÏÈÄÏÅÏÒÅÊ ÇÀÎ
ÍÓÊËÅÈÍÀÒ ÍÀÒÐÈßÁÈÎÑÈÍÒÅÇ ÎÀÎ
ÏÀÍÊËÀÂHEMOFARM KONCERN A.D.
ÏÀÍÒÅÍÎË-ÑÏÐÅÉCHAUVIN ANKERPHARM GmbH
ÏÎÂÈÄÎÍ ÉÎÄZORKA PHARMA
ÑÅËÅÌÈÖÈÍMEDOCHEMIE Ltd.
ÑÈËÜÂÅÄÅÐÌALDO-UNION S.A.
ÑÏÀÐÔËήDr. REDDY`s LABORATORIES Ltd.
ÒÈÌÅÍÒÈÍSmithKline Beecham Pharmaceuticals
ÔÎÐÒÓÌGlaxoSmithKline S.p.A.
ÔÓÇÈÄÈÍ-ÍÀÒÐÈÉÁÈÎÑÈÍÒÅÇ ÎÀÎ
ÖÅÔÎÑÈÍ®ÑÈÍÒÅÇ ÎÀÎ
ÖÅÔÒÀÇÈÄÈÌ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
ÖÅÔÒÐÈÀÊÑÎÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
Òðàâìàòè÷åñêèé øîê
ÂÎËÞÂÅÍFRESENIUS KABI DEUTSCHLAND GmbH
ÈÍÔÓÊÎË ÃÝÊSERUM-WERK BERNBURG AG
ÊÂÈÍÒÀÑÎËÜÁÈÎÑÈÍÒÅÇ ÎÀÎ
ÌÀÔÓÑÎËÁÈÎÑÈÍÒÅÇ ÎÀÎ
ÏÎËÈÎÊÑÈÄÈÍÁÈÎÑÈÍÒÅÇ ÎÀÎ
ÐÅÎÃËÞÌÀÍÁÈÎÕÈÌÈÊ ÎÀÎ
ÐÅÎÏÎËÈÃËÞÊÈÍ Ñ ÃËÞÊÎÇÎÉÁÈÎÕÈÌÈÊ ÎÀÎ
ÐÅÎÏÎËÈÄÅÊÑ®ÁÈÎÑÈÍÒÅÇ ÎÀÎ
ÐÅÔÎÐÒÀÍ® ÃÝÊBERLIN-CHEMIE AG/MENARINI GROUP
ÑÒÀÁÈÇÎË® ÃÝÊ 6%BERLIN-CHEMIE AG/MENARINI GROUP
ÕÀÅÑ-ÑÒÅÐÈËFRESENIUS KABI DEUTSCHLAND GmbH